Patents by Inventor Siegfried Schneider

Siegfried Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120028958
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R4 R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: January 24, 2011
    Publication date: February 2, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Siegfried SCHNEIDER, Dirk KESSLER, Lars van der VEEN, Tobias WUNBERG
  • Publication number: 20120028952
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: January 24, 2011
    Publication date: February 2, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Siegfried SCHNEIDER, Dirk KESSLER, Lars van der VEEN, Tobias WUNBERG
  • Publication number: 20110281838
    Abstract: The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: July 28, 2009
    Publication date: November 17, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tobias Wunberg, Ralph Brueckner, Dirk Kessler, Oliver Kraemer, Darryl McConnell, Siegfried Schneider, Lars van der Veen
  • Publication number: 20110118208
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: March 13, 2009
    Publication date: May 19, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Darryl Mcconnell, Maria Impagnatiello, Dirk Kessler, Oliver Kraemer, Siegfried Schneider, Lars Van Der Veen, Ulrike Weyer-Czernilofsky, Tobias Wunberg
  • Publication number: 20110112087
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: April 20, 2010
    Publication date: May 12, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Lars VAN DER VEEN, Maria Impagnatiello, Darryl McConnell, Siegfried Schneider, Tobias Wunberg
  • Publication number: 20110098275
    Abstract: The present invention encompasses compounds of general formula (1) wherein R1 to R4, m and n are defined as in the specification, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
    Type: Application
    Filed: April 20, 2010
    Publication date: April 28, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tobias Wunberg, Siegfried Schneider, Lars Van Der Veen
  • Publication number: 20100074862
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective HDAC inhibitors.
    Type: Application
    Filed: December 1, 2009
    Publication date: March 25, 2010
    Inventors: Thomas MAIER, Thomas BÄR, Thomas BECKERS, Astrid ZIMMERMANN, Siegfried SCHNEIDER, Volker GEKELER
  • Patent number: 7666868
    Abstract: Compounds of a certain formula (I) in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective HDAC inhibitors.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: February 23, 2010
    Assignee: 4SC AG
    Inventors: Thomas Maier, Thomas Bär, Thomas Beckers, Astrid Zimmermann, Siegfried Schneider, Volker Gekeler
  • Publication number: 20080194921
    Abstract: In a method for automatically evaluating data from at least one clinical study, data may be assessed at a study management system based on at least one management criteria. At least one measured variable may be determined based on the assessed data, and at least one action correlated to at least one facility may be initiated based on the at least one measured variable. The at least one management criteria may be associated with the at least one clinical study.
    Type: Application
    Filed: May 31, 2007
    Publication date: August 14, 2008
    Inventors: Markus Schmidt, Siegfried Schneider, Gudrun Zahlmann
  • Publication number: 20080194920
    Abstract: In a method for determining a parameter in an automatic study and data management system, data is gathered in a knowledge database, and a parameter is determined based the data gathered in the knowledge database. The data is correlated to at least one of a configuration and implementation of a previous clinical study. The parameter is usable for configuring a future clinical study.
    Type: Application
    Filed: May 31, 2007
    Publication date: August 14, 2008
    Inventors: Markus Schmidt, Siegfried Schneider, Gudrun Zahlmann
  • Publication number: 20080176848
    Abstract: Compounds of a certain formula (I) in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective HDAC inhibitors.
    Type: Application
    Filed: March 14, 2006
    Publication date: July 24, 2008
    Applicant: Nycomed GmbH
    Inventors: Thomas Maier, Thomas Bar, Thomas Beckers, Astrid Zimmermann, Siegfried Schneider, Volker Gekeler
  • Patent number: 7283653
    Abstract: In a method and a system for supporting the evaluation of a picture of a patient's eye the picture is displayed on a screen. An image-processing algorithm from a number of image processing algorithms is selected due to a preliminary diagnosis selected from a number of diagnoses which are related to diabetes. Each image-processing algorithm of the number of image processing algorithms is associated with a diagnosis of the number of diagnoses and is designed to search for a pattern which is specific to the respective diagnosis. The selected image-processing algorithm then is applied to the picture and a pattern which is detected by the selected image-processing algorithm is marked on the screen in the picture.
    Type: Grant
    Filed: November 26, 2002
    Date of Patent: October 16, 2007
    Assignee: Siemens Aktiengesellschaft
    Inventors: Gudrun Zahlmann, Volker Schmidt, Siegfried Schneider
  • Publication number: 20070179803
    Abstract: A method is for verifying the feasibility of a medical study using acceptance criteria for patients. The method includes defining target criteria for the study. Based on the acceptance criteria, a patient collective including potential patients is selected from a database containing patient data of patients. The patient data of the patient collective are evaluated based on the target criteria. Finally, a measure for the feasibility of the study is established.
    Type: Application
    Filed: January 31, 2005
    Publication date: August 2, 2007
    Inventors: Klaus Abraham-Fuchs, Rainer Kuth, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Publication number: 20070150223
    Abstract: A method is disclosed for verifying whether an implementation rule assigned to a medical procedure has been observed. The method includes: data correlated with the procedure is automatically entered and stored in a data processing device; test criteria for the data, which are correlated with the implementation rule, are stored in a test system; the procedure is implemented; the test system reads out the data from the data processing device; and the test system evaluates the data based on the test criteria and determines to what degree the implementation rule has been observed.
    Type: Application
    Filed: February 9, 2005
    Publication date: June 28, 2007
    Inventors: Klaus Abraham-Fuchs, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Publication number: 20070150314
    Abstract: A method is disclosed for carrying out quality control of medical data records collected from different but comparable patient collectives within the bounds of a medical plan. In the method, for each data record, a quality control parameter assigned thereto is determined in the same manner. Further, the quality control parameters are evaluated using comparison criteria.
    Type: Application
    Filed: February 7, 2005
    Publication date: June 28, 2007
    Inventors: Klaus Abraham-Fuchs, Rainer Kuth, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Publication number: 20070150313
    Abstract: A method is for evaluating the quality of electronically stored, particularly medical, knowledge data. The knowledge data are stored in a database; quality data correlated with the knowledge data are stored in the database, and; when a user accesses the knowledge data, the quality data are automatically provided to the user.
    Type: Application
    Filed: February 1, 2005
    Publication date: June 28, 2007
    Inventors: Klaus Abraham-Fuchs, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Publication number: 20070150305
    Abstract: During a method for selecting a potential participant for a medical study on the basis of a selection criterion, patient data assigned to a patient are electronically stored. A secondary criterion is assigned to the selection criterion. The patient data are electronically evaluated on the basis of the secondary criterion. Based on this electronic evaluation, a measure for fulfilling the selection criterion is determined for the patient associated with the patient data. The patient is selected as a potential participant on the basis of this measure.
    Type: Application
    Filed: February 1, 2005
    Publication date: June 28, 2007
    Inventors: Klaus Abraham-Fuchs, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Publication number: 20070143691
    Abstract: A method is disclosed for conducting a clinical study according to which an event occurs during the study that requires a collaboration of individuals responsible for the study. The method includes transmitting the event to a collaboration system. The collaboration system determines, based on parameters assigned to the event, a group of individuals responsible for the study required for the collaboration. The collaboration system provides a communications platform for the group. The group carries out the collaboration while using the communications platform. Finally, the collaboration system verifies the collaboration on the basis of predetermined verification criteria.
    Type: Application
    Filed: February 7, 2005
    Publication date: June 21, 2007
    Inventors: Klaus Abraham-Fuchs, Rainer Kuth, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Publication number: 20070143146
    Abstract: A method is disclosed for performing a clinical study on a patient. The study-related or patient-related data is stored in a memory during the study. The memory is readable by a physician who is foreign to the study and is associated with the patient. An information system for a clinical study on a patient encompasses a memory for study-related or patient-related data, which is allocated to the patient, a data input device for storing data in the memory, and a data reading device for reading out the data from the memory. The data reading device is accessible to a physician who is foreign to the study and is associated with the patient.
    Type: Application
    Filed: February 9, 2005
    Publication date: June 21, 2007
    Inventors: Klaus Abraham-Fuchs, Eva Rumpel, Markus Schmidt, Siegfried Schneider, Horst Schreiner, Gudrun Zahlmann
  • Patent number: 7214350
    Abstract: A device for additive-free, catalytically induced oxidation of solid carbon particles and decomposition of chemical compounds, comprising a converter chamber with compartments, in which porous structure catalyst carrier matrix profiles are mounted, so that a space between the internal diameter of catalyst profiles is connected to an inlet connection of the converter chamber, and a space around the external diameter of the catalyst profiles is connected to an outlet connection into the catalyst chamber. The profiles are mounted so that gas particles reach outlets only by passing through porous profiles. Advantageously, a third opening through which liquid, gaseous media, e.g., NO2, O3 or H2O or auxiliary means maybe in front of the porous structures. The porous structures are made of catalytically active material with catalytic action at temperatures below 400° C., preferably below 350° C. and especially below 300° C. The low-temperature below 250° C. by H2O is preferred.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: May 8, 2007
    Assignee: Capital Technology, S.A.
    Inventor: Siegfried Schneider